Repligen Opens European Training and Innovation Center in Breda

New facility will provide customers with hands-on experience and support for the company's bioprocessing solutions.

Apr. 17, 2026 at 12:35pm

Got story updates? Submit your updates here. ›

A photorealistic studio still-life photograph featuring a collection of sleek, polished metal and glass laboratory equipment arranged elegantly on a clean, monochromatic background, conceptually representing Repligen's innovative bioprocessing technologies.Repligen's new European Training and Innovation Center in Breda showcases the company's advanced bioprocessing solutions in a high-tech, interactive setting.Waltham Today

Repligen Corporation has announced the grand opening of its new Repligen Training & Innovation Center (RTIC) at its OPUS Pre-packed Chromatography Columns manufacturing facility in Breda, the Netherlands. The RTIC is designed to provide customers with pre- and post-sales support, as well as a hands-on experience with Repligen's innovative bioprocessing solutions.

Why it matters

The new Breda RTIC is Repligen's third global training and innovation center, joining existing locations in Waltham, Massachusetts and Tokyo, Japan. The facility will enable Repligen to showcase its full range of bioprocessing technologies and provide customers with a comprehensive, interactive experience as the company continues to invest in customer proximity and global support capabilities.

The details

The Breda RTIC features product exhibits and purpose-built demonstration areas, allowing customers to see and interact with Repligen's bioprocessing solutions. On permanent display will be systems such as the KRM 10 Chromatography System, KrosFlo RS 10 and RS30 RPM TFF Systems, and KrosFlo KR2i RPM TFF System, as well as the company's PATsmart Upstream and Downstream Analytical Solutions and Fluid Management products.

  • The Breda RTIC grand opening event was held on April 15, 2026.

The players

Repligen Corporation

A global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems used in the manufacture of biologic drugs.

Got photos? Submit your photos here. ›

The takeaway

Repligen's investment in the new Breda RTIC demonstrates the company's commitment to providing its customers with comprehensive support and a hands-on experience with its innovative bioprocessing solutions, further strengthening its global presence and capabilities.